SpineGuard SA

EPA:ALSGD.PA

0.1218 (EUR) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q4
Revenue 2.2032.4462.0792.2343.0532.5462.1782.2272.5762.2753.3843.4453.9493.6263.9754.1993.833.6333.2592.972.2512.112.2972.3181.9391.9390.9691.5020.751
Cost of Revenue 0.5180.5020.4680.5680.5990.4850.4770.5010.5370.4440.6160.5310.5270.4950.6360.5860.5810.5280.4510.4130.2790.3030.2980.290.1550.3760.1880.2310.116
Gross Profit 1.6851.9441.6111.6662.4552.0611.7011.7262.0391.8312.7682.9143.4223.1313.3393.6133.2493.1052.8082.5571.9721.8071.9992.0281.7841.5630.7811.270.635
Gross Profit Ratio 0.7650.7950.7750.7460.8040.8090.7810.7750.7920.8050.8180.8460.8660.8630.840.860.8480.8550.8620.8610.8760.8560.870.8750.920.8060.8060.8460.846
Reseach & Development Expenses 0.5430.8130.960.610.6420.4660.3610.5240.4620.3530.2940.5550.4830.640.7040.7790.6660.8740.3440.7320.5260.610.4230.5930.5790.0090.005-0.028-0.014
General & Administrative Expenses 00.7760.8030.9960.8230.8350.6150.7790.8880.8520.8710.9850.8740.981.061.0550.9741.0760.8221.1460.8971.010.8340.7720.3740.630.3150.5120.256
Selling & Marketing Expenses 02.0251.9932.0721.8731.8271.4071.2531.2691.3091.6321.8682.4052.4362.7163.3993.1663.4773.4163.0982.7922.6242.4472.3151.291.0690.5350.820.41
SG&A 2.9672.8012.7962.9992.6282.5921.9561.9692.0992.1022.4412.8523.2783.4153.7774.4554.144.5524.2394.2443.6893.6343.2813.0871.6651.6990.851.3310.666
Other Expenses 0-0.058-0.13700000000000000000000.952-0.9854.291-1.708-0.8541.2720.636
Operating Expenses 3.513.5563.623.6093.2693.0592.3172.4932.5612.4552.7353.3273.9113.8884.7975.4594.5835.294.394.6323.8874.1253.7283.5376.5340.00102.5761.288
Operating Income -1.825-1.612-2.009-1.943-0.815-0.998-0.616-0.767-0.522-0.6240.033-0.409-0.234-0.839-1.021-1.526-1.421-2.212-1.641-2.333-2.151-2.328-1.609-1.544-1.56-1.629-0.815-1.284-0.642
Operating Income Ratio -0.829-0.659-0.966-0.87-0.267-0.392-0.283-0.345-0.203-0.2740.01-0.119-0.059-0.231-0.257-0.363-0.371-0.609-0.504-0.786-0.955-1.104-0.701-0.666-0.805-0.841-0.841-0.855-0.855
Total Other Income Expenses Net 0.3460.01-0.193-0.057-0.124-0.153-0.201-0.064-0.609-0.235-0.281-0.326-0.977-0.229-0.718-0.661-0.285-0.26-0.0570.1530.08-0.139-0.255-0.107-0.073-0.003-0.00200
Income Before Tax -1.479-1.603-2.202-2-0.938-1.15-0.817-0.832-1.291-1.389-0.248-0.827-1.248-1.067-1.881-2.244-1.706-2.472-1.698-2.18-2.071-2.467-1.864-1.65-1.633-1.633-0.816-1.284-0.642
Income Before Tax Ratio -0.672-0.655-1.059-0.895-0.307-0.452-0.375-0.373-0.501-0.61-0.073-0.24-0.316-0.294-0.473-0.534-0.445-0.68-0.521-0.734-0.92-1.17-0.812-0.712-0.842-0.842-0.842-0.855-0.855
Income Tax Expense 000.0270.0090.2790.0260.07600.0370-0.3680.02100.019000000000.0760.0690.0730.0030.00200
Net Income -1.479-1.603-2.175-2.009-1.217-1.176-0.893-0.832-1.328-1.3890.12-0.805-1.248-1.086-1.881-2.244-1.706-2.472-1.698-2.18-2.071-2.467-1.864-1.65-1.629-1.636-0.818-1.284-0.642
Net Income Ratio -0.672-0.655-1.046-0.899-0.399-0.462-0.41-0.373-0.515-0.610.035-0.234-0.316-0.299-0.473-0.534-0.445-0.68-0.521-0.734-0.92-1.17-0.812-0.712-0.841-0.844-0.844-0.855-0.855
EPS -0.031-0.034-0.06-0.053-0.036-0.038-0.029-0.032-0.055-0.080.009-0.1-0.19-0.18-0.33-0.42-0.34-0.49-0.34-0.49-0.47-0.57-0.43-0.46-0.54-0.54-0.27-0.5-0.25
EPS Diluted -0.031-0.034-0.054-0.053-0.036-0.038-0.029-0.032-0.055-0.080.009-0.1-0.19-0.18-0.33-0.42-0.34-0.49-0.34-0.49-0.47-0.57-0.43-0.46-0.54-0.54-0.27-0.5-0.25
EBITDA -1.825-1.548-1.894-1.821-0.538-0.85-0.36-0.539-0.741-0.8530.33-0.311-0.179-0.781-1.377-1.785-1.356-2.151-1.593-2.281-2.101-2.286-1.559-1.48-1.509-1.531-0.765-1.224-0.612
EBITDA Ratio -0.829-0.633-0.911-0.815-0.176-0.334-0.165-0.242-0.288-0.3750.098-0.09-0.045-0.215-0.346-0.425-0.354-0.592-0.489-0.768-0.933-1.083-0.679-0.638-0.778-0.79-0.79-0.815-0.815